224 related articles for article (PubMed ID: 29230023)
1. Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD.
Myer NM; Boland JR; Faraone SV
Mol Psychiatry; 2018 Sep; 23(9):1929-1936. PubMed ID: 29230023
[TBL] [Abstract][Full Text] [Related]
2. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
Bonvicini C; Faraone SV; Scassellati C
Mol Psychiatry; 2016 Jul; 21(7):872-84. PubMed ID: 27217152
[TBL] [Abstract][Full Text] [Related]
3. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.
Kereszturi E; Tarnok Z; Bognar E; Lakatos K; Farkas L; Gadoros J; Sasvari-Szekely M; Nemoda Z
Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1431-5. PubMed ID: 18214865
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.
Froehlich TE; Epstein JN; Nick TG; Melguizo Castro MS; Stein MA; Brinkman WB; Graham AJ; Langberg JM; Kahn RS
J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1129-1139.e2. PubMed ID: 22024001
[TBL] [Abstract][Full Text] [Related]
5. A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.
McGough JJ; McCracken JT; Loo SK; Manganiello M; Leung MC; Tietjens JR; Trinh T; Baweja S; Suddath R; Smalley SL; Hellemann G; Sugar CA
J Am Acad Child Adolesc Psychiatry; 2009 Dec; 48(12):1155-64. PubMed ID: 19858760
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic and noradrenergic gene polymorphisms and response to methylphenidate in korean children with attention-deficit/hyperactivity disorder: is there an interaction?
Hong SB; Kim JW; Cho SC; Shin MS; Kim BN; Yoo HJ
J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):343-52. PubMed ID: 23083021
[TBL] [Abstract][Full Text] [Related]
7. A current update on ADHD pharmacogenomics.
Kieling C; Genro JP; Hutz MH; Rohde LA
Pharmacogenomics; 2010 Mar; 11(3):407-19. PubMed ID: 20235795
[TBL] [Abstract][Full Text] [Related]
8. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
[TBL] [Abstract][Full Text] [Related]
9. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).
Kooij JS; Boonstra AM; Vermeulen SH; Heister AG; Burger H; Buitelaar JK; Franke B
Am J Med Genet B Neuropsychiatr Genet; 2008 Mar; 147B(2):201-8. PubMed ID: 17955457
[TBL] [Abstract][Full Text] [Related]
10. Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD.
Tharoor H; Lobos EA; Todd RD; Reiersen AM
Am J Med Genet B Neuropsychiatr Genet; 2008 Jun; 147B(4):527-30. PubMed ID: 17948872
[TBL] [Abstract][Full Text] [Related]
11. Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.
Froehlich TE; McGough JJ; Stein MA
CNS Drugs; 2010 Feb; 24(2):99-117. PubMed ID: 20088618
[TBL] [Abstract][Full Text] [Related]
12. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
[TBL] [Abstract][Full Text] [Related]
13. Noradrenergic genes polymorphisms and response to methylphenidate in children with ADHD: A systematic review and meta-analysis.
Yuan D; Zhang M; Huang Y; Wang X; Jiao J; Huang Y
Medicine (Baltimore); 2021 Nov; 100(46):e27858. PubMed ID: 34797323
[TBL] [Abstract][Full Text] [Related]
14. Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.
Retz W; Rösler M; Kissling C; Wiemann S; Hünnerkopf R; Coogan A; Thome J; Freitag C
J Neural Transm (Vienna); 2008; 115(2):323-9. PubMed ID: 17994190
[TBL] [Abstract][Full Text] [Related]
15. Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment.
Cho SC; Kim BN; Cummins TD; Kim JW; Bellgrove MA
J Psychopharmacol; 2012 Mar; 26(3):380-9. PubMed ID: 21628343
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
Roman T; Rohde LA; Hutz MH
Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031
[TBL] [Abstract][Full Text] [Related]
17. A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.
Hegvik TA; Jacobsen KK; Fredriksen M; Zayats T; Haavik J
J Neural Transm (Vienna); 2016 Aug; 123(8):859-65. PubMed ID: 27091191
[TBL] [Abstract][Full Text] [Related]
18. Catechol-O-methyltransferase Val158-Met polymorphism and a response of hyperactive-impulsive symptoms to methylphenidate: A replication study from South Korea.
Park S; Kim JW; Kim BN; Shin MS; Yoo HJ; Cho SC
J Psychopharmacol; 2014 Jul; 28(7):671-6. PubMed ID: 24763183
[TBL] [Abstract][Full Text] [Related]
19. Adrenergic neurotransmitter system transporter and receptor genes associated with atomoxetine response in attention-deficit hyperactivity disorder children.
Yang L; Qian Q; Liu L; Li H; Faraone SV; Wang Y
J Neural Transm (Vienna); 2013 Jul; 120(7):1127-33. PubMed ID: 23266789
[TBL] [Abstract][Full Text] [Related]
20. Interactions Between Early Trauma and Catechol-O-Methyltransferase Genes on Inhibitory Deficits in Children With ADHD.
Park S; Kim BN; Kim JW; Shin MS; Yoo HJ; Cho SC
J Atten Disord; 2017 Feb; 21(3):183-189. PubMed ID: 25063767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
